These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 23360500)

  • 1. Structure of a glycomimetic ligand in the carbohydrate recognition domain of C-type lectin DC-SIGN. Structural requirements for selectivity and ligand design.
    Thépaut M; Guzzi C; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Varga N; Chabrol E; Rojo J; Bernardi A; Angulo J; Nieto PM; Fieschi F
    J Am Chem Soc; 2013 Feb; 135(7):2518-29. PubMed ID: 23360500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and quantitative analysis of two independent binding modes of a small ligand responsible for DC-SIGN clustering.
    Guzzi C; Alfarano P; Sutkeviciute I; Sattin S; Ribeiro-Viana R; Fieschi F; Bernardi A; Weiser J; Rojo J; Angulo J; Nieto PM
    Org Biomol Chem; 2016 Jan; 14(1):335-44. PubMed ID: 26611567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unique DC-SIGN clustering activity of a small glycomimetic: A lesson for ligand design.
    Sutkeviciute I; Thépaut M; Sattin S; Berzi A; McGeagh J; Grudinin S; Weiser J; Le Roy A; Reina JJ; Rojo J; Clerici M; Bernardi A; Ebel C; Fieschi F
    ACS Chem Biol; 2014 Jun; 9(6):1377-85. PubMed ID: 24749535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The carbohydrate recognition domain of Langerin reveals high structural similarity with the one of DC-SIGN but an additional, calcium-independent sugar-binding site.
    Chatwell L; Holla A; Kaufer BB; Skerra A
    Mol Immunol; 2008 Apr; 45(7):1981-94. PubMed ID: 18061677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational-Differential Design of Highly Specific Glycomimetic Ligands: Targeting DC-SIGN and Excluding Langerin Recognition.
    Porkolab V; Chabrol E; Varga N; Ordanini S; Sutkevičiu Tė I; Thépaut M; García-Jiménez MJ; Girard E; Nieto PM; Bernardi A; Fieschi F
    ACS Chem Biol; 2018 Mar; 13(3):600-608. PubMed ID: 29272097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting of dendritic cell-specific intercellular adhesion molecule-3-grabbing nonintegrin (DC-SIGN) with mannose-based glycomimetics: synthesis and interaction studies of bis(benzylamide) derivatives of a pseudomannobioside.
    Varga N; Sutkeviciute I; Guzzi C; McGeagh J; Petit-Haertlein I; Gugliotta S; Weiser J; Angulo J; Fieschi F; Bernardi A
    Chemistry; 2013 Apr; 19(15):4786-97. PubMed ID: 23417900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis reveals selective recognition of glycans by the dendritic cell receptors DC-SIGN and Langerin.
    Holla A; Skerra A
    Protein Eng Des Sel; 2011 Sep; 24(9):659-69. PubMed ID: 21540232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A glycomimetic compound inhibits DC-SIGN-mediated HIV infection in cellular and cervical explant models.
    Berzi A; Reina JJ; Ottria R; Sutkeviciute I; Antonazzo P; Sanchez-Navarro M; Chabrol E; Biasin M; Trabattoni D; Cetin I; Rojo J; Fieschi F; Bernardi A; Clerici M
    AIDS; 2012 Jan; 26(2):127-37. PubMed ID: 22045343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking, synthesis, and NMR studies of mannosyl trisaccharide ligands for DC-SIGN lectin.
    Reina JJ; Díaz I; Nieto PM; Campillo NE; Páez JA; Tabarani G; Fieschi F; Rojo J
    Org Biomol Chem; 2008 Aug; 6(15):2743-54. PubMed ID: 18633532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of novel DC-SIGN ligands with an alpha-fucosylamide anchor.
    Timpano G; Tabarani G; Anderluh M; Invernizzi D; Vasile F; Potenza D; Nieto PM; Rojo J; Fieschi F; Bernardi A
    Chembiochem; 2008 Aug; 9(12):1921-30. PubMed ID: 18655085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x.
    van Die I; van Vliet SJ; Nyame AK; Cummings RD; Bank CM; Appelmelk B; Geijtenbeek TB; van Kooyk Y
    Glycobiology; 2003 Jun; 13(6):471-8. PubMed ID: 12626400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into molecular recognition of Lewis(X) mimics by DC-SIGN using NMR and molecular modelling.
    Guzzi C; Angulo J; Doro F; Reina JJ; Thépaut M; Fieschi F; Bernardi A; Rojo J; Nieto PM
    Org Biomol Chem; 2011 Oct; 9(22):7705-12. PubMed ID: 21984435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epitope mapping on the dendritic cell-specific ICAM-3-grabbing non-integrin (DC-SIGN) pathogen-attachment factor.
    Sierra-Filardi E; Estecha A; Samaniego R; Fernández-Ruiz E; Colmenares M; Sánchez-Mateos P; Steinman RM; Granelli-Piperno A; Corbí AL
    Mol Immunol; 2010 Jan; 47(4):840-8. PubMed ID: 19879650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mannose hyperbranched dendritic polymers interact with clustered organization of DC-SIGN and inhibit gp120 binding.
    Tabarani G; Reina JJ; Ebel C; Vivès C; Lortat-Jacob H; Rojo J; Fieschi F
    FEBS Lett; 2006 May; 580(10):2402-8. PubMed ID: 16616922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gold manno-glyconanoparticles: multivalent systems to block HIV-1 gp120 binding to the lectin DC-SIGN.
    Martínez-Avila O; Hijazi K; Marradi M; Clavel C; Campion C; Kelly C; Penadés S
    Chemistry; 2009 Sep; 15(38):9874-88. PubMed ID: 19681073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural basis for selective recognition of oligosaccharides by DC-SIGN and DC-SIGNR.
    Feinberg H; Mitchell DA; Drickamer K; Weis WI
    Science; 2001 Dec; 294(5549):2163-6. PubMed ID: 11739956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 1,2-Mannobioside mimic: synthesis, DC-SIGN interaction by NMR and docking, and antiviral activity.
    Reina JJ; Sattin S; Invernizzi D; Mari S; Martínez-Prats L; Tabarani G; Fieschi F; Delgado R; Nieto PM; Rojo J; Bernardi A
    ChemMedChem; 2007 Jul; 2(7):1030-6. PubMed ID: 17508368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural basis for distinct ligand-binding and targeting properties of the receptors DC-SIGN and DC-SIGNR.
    Guo Y; Feinberg H; Conroy E; Mitchell DA; Alvarez R; Blixt O; Taylor ME; Weis WI; Drickamer K
    Nat Struct Mol Biol; 2004 Jul; 11(7):591-8. PubMed ID: 15195147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DC-SIGN antagonists, a potential new class of anti-infectives.
    Anderluh M; Jug G; Svajger U; Obermajer N
    Curr Med Chem; 2012; 19(7):992-1007. PubMed ID: 22257062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cross-presentation through langerin and DC-SIGN targeting requires different formulations of glycan-modified antigens.
    Fehres CM; Kalay H; Bruijns SC; Musaafir SA; Ambrosini M; van Bloois L; van Vliet SJ; Storm G; Garcia-Vallejo JJ; van Kooyk Y
    J Control Release; 2015 Apr; 203():67-76. PubMed ID: 25656175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.